---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-005872"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2023-02-23T23:59:59+00:00"
generated_at: "2026-06-19T02:19:42.475905+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience issues $200K convertible debenture at 8% interest, with warrants and commitment shares

## Summary
- Issued $200,000 convertible debenture to Firstfire Global Opportunities Fund at $180,000 purchase price (10% OID).
- Debenture carries 8% annual interest, matures Feb 17, 2024; convertible at $0.52 per share initially.
- Also issued warrant to buy 100,000 shares at $0.75 and 33,333 commitment shares as inducement.
- Proceeds used for working capital; placement agent fee $14,400.
- Exchange cap of 2,436,045 shares (19.99% of outstanding) unless shareholder approval obtained.

## SEC filing metadata
- accession: 0001493152-23-005872
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2023-02-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315223005872/0001493152-23-005872-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315223005872/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-005872
- JSON: https://secwatch.observer/filing/0001493152-23-005872.json
- Plain text: https://secwatch.observer/filing/0001493152-23-005872.txt

## Key facts
- Debt Financings
  INVO Fertility, Inc. incurred convertible notes of $200,000 with Firstfire Global Opportunities Fund, LLC at 8% per annum maturing February 17, 2024.
  - Instrument: convertible notes
  - Principal: $200,000
  - Counterparty: Firstfire Global Opportunities Fund, LLC
  - Rate: 8% per annum
  - Maturity: February 17, 2024
  - Event: incurrence
  source text: On February 17 2023 (the “Closing”), INVO Bioscience, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with Firstfire Global Opportunities Fund, LLC, an accredited investor (the “Buyer”) for the purchase of (i) a convertible debenture of the Company (the “Debenture”) in the aggregate original principal amount of $200,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315223005872/0001493152-23-005872-index.htm
- Material Agreements
  INVO Fertility, Inc. entered into Purchase Agreement with Firstfire Global Opportunities Fund, LLC valued at $200,000 (effective 2023-02-17).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Firstfire Global Opportunities Fund, LLC
  - Value: $200,000
  - Effective: 2023-02-17
  source text: On February 17 2023 (the “Closing”), INVO Bioscience, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with Firstfire Global Opportunities Fund, LLC, an accredited investor (the “Buyer”) for the purchase of (i) a convertible debenture of the Company (the “Debenture”) in the aggregate original principal amount of $200,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315223005872/0001493152-23-005872-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.